| abstract |
The present invention provides a novel drug for improving the recovery of corneal sensitivity and symptom of dry eye after corneal surgery, and this drug contains a Rho protein inhibitor, so that after cataract surgery, LASIK surgery, PRK After surgery, after corneal transplantation surgery, it is useful for the improvement of corneal hyposensitivity and dry eye symptoms associated with corneal neurodegeneration such as neuroparalytic keratopathy, corneal ulcer, diabetic keratopathy. |